These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34376738)

  • 1. Exploring the selectivity of guanine scaffold in anticancer drug development by computational repurposing approach.
    Sherin DR; Manojkumar TK
    Sci Rep; 2021 Aug; 11(1):16251. PubMed ID: 34376738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs.
    Sohraby F; Aryapour H
    Semin Cancer Biol; 2021 Jan; 68():249-257. PubMed ID: 32360530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
    Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
    Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing old drugs to fight multidrug resistant cancers.
    Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
    Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An
    Jubie S; Durai U; Latha S; Ayyamperumal S; Wadhwani A; Prabha T
    Curr Drug Res Rev; 2021; 13(1):73-83. PubMed ID: 32955008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review.
    Selvaraj J; Prabha T; Yadav N
    Curr Drug Res Rev; 2021; 13(1):3-15. PubMed ID: 32838729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
    Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
    Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performing an In Silico Repurposing of Existing Drugs by Combining Virtual Screening and Molecular Dynamics Simulation.
    Sohraby F; Bagheri M; Aryapour H
    Methods Mol Biol; 2019; 1903():23-43. PubMed ID: 30547434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of computational approaches to understand cancer biology for informed drug repurposing.
    Ahmed F; Samantasinghar A; Soomro AM; Kim S; Choi KH
    J Biomed Inform; 2023 Jun; 142():104373. PubMed ID: 37120047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
    Chen H; Wu J; Gao Y; Chen H; Zhou J
    Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity.
    Castillo-González D; Pérez-Machado G; Pallardó F; Garrigues-Pelufo TM; Cabrera-Pérez MA
    Curr Top Med Chem; 2012; 12(24):2843-56. PubMed ID: 23368106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
    Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
    J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for breast cancer therapy: Old weapon for new battle.
    Aggarwal S; Verma SS; Aggarwal S; Gupta SC
    Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
    Chen HR; Sherr DH; Hu Z; DeLisi C
    BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing in the Development of Anticancer Agents.
    Olgen S; Kotra LP
    Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocomputing drug repurposing toward targeted therapies.
    Cardone L
    Aging (Albany NY); 2016 Nov; 8(11):2609-2610. PubMed ID: 27920407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.